+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

New discovery related to gum disease



New discovery related to gum disease







A UofL scientist has discovered a mechanism to reduce inflammation and subsequent bone loss related to gum disease.

Accession: 036573777

Download citation: RISBibTeXText


Related references

Diverse therapeutic targets and biomarkers for Alzheimer's disease and related dementias: report on the Alzheimer's Drug Discovery Foundation 2012 International Conference on Alzheimer's Drug Discovery. Alzheimer's Research and Therapy 5(1): 5-5, 2013

IgG4-related systemic disease: the age of discovery. Current Opinion in Rheumatology 23(1): 72-73, 2011

Walking on a tissue-specific disease-protein-complex heterogeneous network for the discovery of disease-related protein complexes. Biomed Research International 2013: 732650, 2013

Idiopathic orbital inflammation: a new dimension with the discovery of immunoglobulin G4-related disease. Current Opinion in Ophthalmology 23(5): 415-419, 2012

Metabolic phenotyping may aid discovery of novel biomarkers related to risk of cardiovascular disease. Biomarkers in Medicine 2(3): 215-217, 2008

Technologies of disease-related gene discovery using preclinical models of stroke. Methods in Molecular Medicine 104: 253-264, 2005

Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proceedings of the National Academy of Sciences of the United States of America 94(6): 2150-2155, 1997

Drug discovery: estrogen-related compounds in mouse models of Alzheimer's disease. Journal of Molecular Neuroscience 24(1): 145-147, 2004

Literature-related discovery techniques applied to ocular disease: a vitreous restoration example. Current Opinion in Ophthalmology 24(6): 606-610, 2013

Translational experimental therapeutics: The translation of laboratory-based discovery into disease-related therapy. Mount Sinai Journal of Medicine new York 74(1): 7-14, 2007

Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors. Experimental Neurology 223(2): 304-310, 2010

Bridging the molecular divide: alcohol-induced downregulation of PAX9 and tumour development. Journal of Pathology 244(4): 386-388, 2018

Beyond amyloid: a diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementias. Alzheimer's Research and Therapy 3(6): 36, 2011

Strategy of SNPs-based discovery of disease-related genes as the possible targets of drug development. Japanese Journal of Pharmacology 82(Suppl 1): 17P, 2000